FindTrial
Sign In

Evaluation of Adverse Drug Reactions in patients receiving Antiretroviral Therapy

Evaluation OF Adverse Drug Reactions In Patients On Antiretroviral Therapy Attending Antiretroviral Therapy Centre In A Tertiary Care Hospital Of Eastern India – A Cross Sectional Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/05/067521
Enrollment
144
Registered
2024-05-17
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B20- Human immunodeficiency virus [HIV]disease

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Government Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients of any gender on Anti Retroviral Therapy (ART) attending ART Centre. 2) Patients of age above 18 years.

Exclusion criteria

Exclusion criteria: 1) Patients who disagree to give consent.

Design outcomes

Primary

MeasureTime frame
Evaluation of Adverse Drug Reactions in Patients on Anti-Retroviral TherapyTimepoint: At baseline—

Secondary

MeasureTime frame
i.To estimate the Severity & Preventability of ADRs in patients on ART. ii. To determine risk factors associated with the ADRs in patients on ART. iii. To evaluate ADRs in patients with co-infection receiving ART. iv. To assess whether demographic factors are responsible for the ADRs.Timepoint: At baseline—

Countries

India

Contacts

Public ContactGunjan Gayen

R G Kar Medical College And Hospital

drtapasbera@gmail.com6290918629

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026